Fulgent Genetics (MEX:FLGT) E10: MXN35.64 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:FLGT Fulgent Genetics Inc MEX:FLGT
65 GF Score
Price MXN319.51
GF Value MXN387.04
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Fulgent Genetics E10?

Fulgent Genetics MEX:FLGT 65 E10 is MXN35.64 as of Jun. 2026. GuruFocus rates MEX:FLGT with a GF Score™ of 65/100 and a GF Value™ of MXN387.04 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Fulgent Genetics's adjusted earnings per share data for the three months ended in Jun. 2026 was MXN-18.321. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is MXN35.64 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Fulgent Genetics's average E10 Growth Rate was -1.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-08-21), Fulgent Genetics's current stock price is MXN319.51. Fulgent Genetics's E10 for the quarter that ended in Jun. 2026 was MXN35.64. Fulgent Genetics's Shiller PE Ratio of today is 8.96.

During the past 12 years, the highest Shiller PE Ratio of Fulgent Genetics was 12.66. The lowest was 6.01. And the median was 8.41.


Fulgent Genetics  (MEX:FLGT) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Fulgent Genetics's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=319.51/35.64
=8.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Shiller P/E Ratio of Fulgent Genetics was 12.66. The lowest was 6.01. And the median was 8.41.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Fulgent Genetics E10 Related Terms


Fulgent Genetics E10 Historical Data

* Premium members only.

The historical data trend for Fulgent Genetics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fulgent Genetics E10 Chart

Fulgent Genetics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 42.60

Fulgent Genetics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.51 35.99 42.60 72.79 35.64

MEX:FLGT vs MYGN, CSTL, BDSX: E10 Comparison

For the Diagnostics & Research subindustry, Fulgent Genetics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fulgent Genetics Shiller PE Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Fulgent Genetics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Fulgent Genetics's Shiller PE Ratio falls into.


MEX:FLGT
65GF Score
Fulgent Genetics Inc MEX:FLGT
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fulgent Genetics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Fulgent Genetics's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-18.321/333.9520*333.9520
=-18.321

Current CPI (Jun. 2026) = 333.9520.

Fulgent Genetics Quarterly Data

per share eps CPI Adj_EPS
201609 -8.508 241.428 -11.769
201612 1.031 241.432 1.426
201703 0.188 243.801 0.258
201706 -0.026 244.955 -0.035
201709 -1.089 246.819 -1.473
201712 -1.964 246.524 -2.661
201803 -1.998 249.554 -2.674
201806 -1.179 251.989 -1.562
201809 -0.561 252.439 -0.742
201812 -0.982 251.233 -1.305
201903 -1.940 254.202 -2.549
201906 0.384 256.143 0.501
201909 1.579 256.759 2.054
201912 -0.189 256.974 -0.246
202003 -2.110 258.115 -2.730
202006 3.231 257.797 4.185
202009 43.740 260.280 56.121
202012 122.535 260.474 157.101
202103 133.275 264.877 168.031
202106 51.557 271.696 63.371
202109 80.809 274.310 98.379
202112 68.517 278.802 82.070
202203 98.161 287.504 114.019
202206 7.444 296.311 8.390
202209 1.207 296.808 1.358
202212 -15.597 296.797 -17.550
202303 -9.373 301.836 -10.370
202306 -6.515 305.109 -7.131
202309 -7.664 307.789 -8.315
202312 -72.989 306.746 -79.463
202403 -7.468 312.332 -7.985
202406 -5.313 314.175 -5.647
202409 -9.451 315.301 -10.010
202412 -3.963 315.605 -4.193
202503 -7.570 319.799 -7.905
202506 -11.674 322.561 -12.086
202509 -3.852 324.800 -3.961
202512 -13.684 324.054 -14.102
202603 -14.426 330.213 -14.589
202606 -18.321 333.952 -18.321

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of MXN35.64 mean?
Fulgent Genetics (MEX:FLGT) has a E10 of MXN35.64 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Fulgent Genetics and its competitors.
Is Fulgent Genetics' E10 too high?
Fulgent Genetics' current E10 is MXN35.64. Overall, Fulgent Genetics has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Fulgent Genetics' E10 compare to MYGN and CSTL?
Fulgent Genetics' E10 of MXN35.64 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Diagnostics & Research company?
A good E10 depends on the Medical Diagnostics & Research industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Fulgent Genetics and its competitors. Fulgent Genetics's current E10 is MXN35.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fulgent Genetics stock overvalued right now?
Based on GuruFocus' analysis, Fulgent Genetics (MEX:FLGT) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN387.04, compared to a current price of MXN319.51 — trading 17.4% below its estimated fair value. The current E10 is MXN35.64. Fulgent Genetics' overall GF Score™ is 65/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Fulgent Genetics (MEX:FLGT), the current E10 is MXN35.64 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fulgent Genetics (MEX:FLGT) Overvalued in 2026?

Based on GuruFocus' analysis, Fulgent Genetics stock appears to be undervalued. The current stock price of MXN319.51 is trading 17.4% below its estimated GF Value™ of MXN387.04. GuruFocus considers Fulgent Genetics to be Modestly Undervalued.

Key valuation signals for MEX:FLGT:

  • E10: MXN35.64
  • GF Value™: MXN387.04 vs. price of MXN319.51 (17.4% below fair value)
  • GF Score™: 65/100 with 3 warning signs

No single metric tells the full story. See the MEX:FLGT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fulgent Genetics Business Description

Other Exchanges FLGT:USA
Address 4399 Santa Anita Avenue, El Monte, CA, USA, 91731
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.
65GF Score

Get the complete analysis for MEX:FLGT

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN319.51
Price
MXN387.04
GF Value